Literature DB >> 11085590

A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34.

I P Blair1, C L Bennett, A Abel, B A Rabin, J W Griffin, K H Fischbeck, D R Cornblath, P F Chance.   

Abstract

Amyotrophic lateral sclerosis (ALS) denotes a heterogeneous group of neurodegenerative disorders affecting upper and lower motor neurons. ALS4 is a juvenile-onset, autosomal dominant form of ALS that is characterized by slow progression, distal limb weakness and amyotrophy, and pyramidal signs associated with severe loss of motor neurons in the brain and spinal cord. The ALS4 locus was recently mapped by linkage analysis to a large genetic interval on chromosome 9q34. By undertaking extensive genetic linkage analysis, we have significantly refined the ALS4 locus to a critical interval of less than 3 cM, flanked by D9S149 and D9S1198. Previous physical mapping in this region has indicated that this critical interval spans approximately 500 kb. Seventeen putative transcripts have been localized within this interval including 7 characterized genes, 2 partially characterized genes, and 8 "anonymous" expressed sequence tags . These are therefore positional candidate genes for the ALS4 locus. We have also undertaken mutation analysis and genetic mapping to investigate and exclude candidate genes, including RING3L/ORFX and RALGDS, from a pathogenic role in ALS4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085590     DOI: 10.1007/pl00022976

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  8 in total

1.  Transcription termination by nuclear RNA polymerases.

Authors:  Patricia Richard; James L Manley
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

2.  A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2.

Authors:  Halah Abalkhail; John Mitchell; James Habgood; Richard Orrell; Jacqueline de Belleroche
Journal:  Am J Hum Genet       Date:  2003-06-26       Impact factor: 11.025

Review 3.  Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia.

Authors:  Edward D Huey; Nicole Armstrong; Parastoo Momeni; Jordan Grafman
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

4.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

Authors:  Ying-Zhang Chen; Craig L Bennett; Huy M Huynh; Ian P Blair; Imke Puls; Joy Irobi; Ines Dierick; Annette Abel; Marina L Kennerson; Bruce A Rabin; Garth A Nicholson; Michaela Auer-Grumbach; Klaus Wagner; Peter De Jonghe; John W Griffin; Kenneth H Fischbeck; Vincent Timmerman; David R Cornblath; Phillip F Chance
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

5.  The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases.

Authors:  Larissa Arning; Jörg T Epplen; Elisa Rahikkala; Corinna Hendrich; Albert C Ludolph; Anne-Dorte Sperfeld
Journal:  Neurogenetics       Date:  2012-11-06       Impact factor: 2.660

Review 6.  The involvement of DNA-damage and -repair defects in neurological dysfunction.

Authors:  Avanti Kulkarni; David M Wilson
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

7.  A novel locus for distal motor neuron degeneration maps to chromosome 7q34-q36.

Authors:  Sumana Gopinath; Ian P Blair; Marina L Kennerson; Jennifer C Durnall; Garth A Nicholson
Journal:  Hum Genet       Date:  2007-03-13       Impact factor: 5.881

Review 8.  Disengaging polymerase: terminating RNA polymerase II transcription in budding yeast.

Authors:  Hannah E Mischo; Nick J Proudfoot
Journal:  Biochim Biophys Acta       Date:  2012-10-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.